ESR1 and breast carcinoma: Our results are in agreement with those from six geographical regions in Nigeria and Senegal on population differences in breast cancer which similarly reported that luminal A were 27%, luminal B were (2%) and HER2+/ER- were 15% and triple negative were 27% and unclassified were 28% [52].